Dr. Peter Adamson, Chair of the Children’s Oncology Group addresses the issue of National Institute of Health (NIH) funding at risk in the current economic climate and its impact on children’s cancer research. Dr. Adamson states, "We are, however, entering an era of unprecedented discovery. We now have the tools to uncover the underlying basis of all childhood cancers – and therefore the potential to transform the way we treat children with these dreaded diseases….At the same time, though, that essential factor in the last generation of major advances – NIH funding – is now at risk." "This impacts all types of children’s cancers….including pediatric brain tumors."

Read the article…